NSISN Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
NSISN FAQ
What was Novonesis A/S (UK)’s price range in the past 12 months?
Currently, no data Available
What is Novonesis A/S (UK)’s market cap?
Novonesis A/S (UK)’s market cap is $525.05B.
When is Novonesis A/S (UK)’s upcoming earnings report date?
Novonesis A/S (UK)’s upcoming earnings report date is Aug 20, 2026 which is in 13 days.
How were Novonesis A/S (UK)’s earnings last quarter?
Novonesis A/S (UK) released its earnings results on May 05, 2026. The company reported $8.492 earnings per share for the quarter, missing the consensus estimate of $13.908 by -$5.416.
Is Novonesis A/S (UK) overvalued?
According to Wall Street analysts Novonesis A/S (UK)’s price is currently Undervalued.
Does Novonesis A/S (UK) pay dividends?
Novonesis A/S (UK) does not currently pay dividends.
What is Novonesis A/S (UK)’s EPS estimate?
Novonesis A/S (UK)’s EPS estimate is 10.55.
How many shares outstanding does Novonesis A/S (UK) have?
Novonesis A/S (UK) has 414,555,050 shares outstanding.
What happened to Novonesis A/S (UK)’s price movement after its last earnings report?
Novonesis A/S (UK) reported an EPS of $8.492 in its last earnings report, missing expectations of $13.908. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Novonesis A/S (UK)?
Currently, no hedge funds are holding shares in MX:NSISN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Novonesis A/S (UK)
Established in 1925 and based in Bagsvaerd, Denmark, Novozymes A/S is a global provider of biological solutions, specializing in the development and sale of industrial enzymes, microorganisms, and probiotics. The company's reach extends internationally, serving markets in Denmark, the rest of Europe, North America, Asia Pacific, the Middle East, Africa, and Latin America. Novozymes' diverse portfolio includes protein solutions for the food and beverage sector, alongside a comprehensive suite of cleaning and hygiene offerings for industrial, medical, and household applications, such as drain openers, septic tank treatments, ware washing, and professional laundry. In agriculture, they supply solutions for various crops like corn, cotton, soybeans, and wheat, focusing on bioyield and biocontrol, in addition to animal health and nutrition products and aquaculture systems for warm water species. The company actively supports sustainable industrial processes with contributions to bioenergy (including ethanol, biodiesel, renewable diesel, biogas, and wastewater treatment), biorefining (encompassing fiber modification, bleach boosting, deposit control, starch modification, carbon capture), and applications for textiles and leather. Their extensive range of enzyme solutions, such as lipases, proteases, oxidoreductases, and carbohydrases, are crucial for processes like corn and wheat separation, liquefaction, and saccharification. Furthermore, Novozymes addresses human health with solutions targeting brain, oral, protective, immune, and gastrointestinal well-being, while also engaging in areas like biocatalysis, cell culture, and diagnostics.
NSISN Revenue Breakdown
28.53% Household Care
24.83% Bioenergy
22.07% Food, Beverages & Human Health
12.82% Grain & Tech Processing
11.75% Agriculture & Animal Health
NSISN Stock 12 Month Forecast
Average Price Target
$1,291.03